2Amat M, Gome z JM, Biondo S, et al. Prognostic factors of thyroid function following surgical therapy in Graves'-Basedow' disease. Med Clin(Bare) ,2001,116(5 ) :487-490.
3[12]Lazarus JH, Obuobie K. Thyroid disorder-an update. Postgrad Med J, 2000, 76(899): 529
4[13]Quadro L, Panariello L, Salvatore D, et al. Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab, 1994, 79(2): 590
5[14]Bongarzone I, Pierotti MA, Monzini N,et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 1989, 4(12): 1457
6[15]Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med, 2002, 43(9): 1188
7[1]Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg, 2001, 25(3): 307
8[2]Gimm O, Brauckhoff M, Thanh PN, et al. An update of thyroid surgery. Eur J Nucl Med, 2002, 29(supple 2): s447
9[3]Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 1994, 97(5): 418
10[4]Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab, 1992, 75(3): 714
